Literature DB >> 24729929

Inclusion of South African adolescents in HIV vaccine trials.

David H Adler1.   

Abstract

South Africa has more people living with HIV than any other nation. The HIV epidemic in South Africa is being driven by new infections among adolescents. Inclusion of adolescents in HIV vaccine trials is essential for successful vaccine development, however, recruitment and retention of at-risk South African adolescents into these trials poses a number of legal, ethical and operational challenges. This article discusses the South African ethico-legal context in which future adolescent HIV vaccine trials would be conducted followed by a review of available data regarding strategies for recruitment into these trials and retention of trial participants.

Entities:  

Keywords:  Adolescent; HIV vaccine trial; South Africa; recruitment; retention

Year:  2012        PMID: 24729929      PMCID: PMC3983992          DOI: 10.5897/JAHR11.065

Source DB:  PubMed          Journal:  J AIDS HIV Res


  18 in total

1.  Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project.

Authors:  Paulette D Stanford; Dina A Monte; Felecia M Briggs; Patricia M Flynn; Mary Tanney; Jonas H Ellenberg; Kathy L Clingan; Audrey Smith Rogers
Journal:  J Adolesc Health       Date:  2003-03       Impact factor: 5.012

Review 2.  Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.

Authors:  Glenda Gray; Susan Buchbinder; Ann Duerr
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

3.  Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.

Authors:  Georgina Giocos; Ashraf Kagee; Leslie Swartz
Journal:  AIDS Behav       Date:  2007-08-01

4.  Child consent in South African law: implications for researchers, service providers and policy-makers.

Authors:  Ann Strode; Catherine Slack; Zaynab Essack
Journal:  S Afr Med J       Date:  2011-09-05

5.  Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials.

Authors:  Heather B Jaspan; Jessica R Berwick; Landon Myer; Catherine Mathews; Alan J Flisher; Robin Wood; Linda-Gail Bekker
Journal:  J Adolesc Health       Date:  2006-07-31       Impact factor: 5.012

6.  A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.

Authors:  H B Jaspan; N F Soka; C Mathews; A J Flisher; D Mark; K Middelkoop; R Wood; L-G Bekker
Journal:  Int J STD AIDS       Date:  2010-03       Impact factor: 1.359

Review 7.  Unsafe sexual behaviour in South African youth.

Authors:  Liberty Eaton; Alan J Flisher; Leif E Aarø
Journal:  Soc Sci Med       Date:  2003-01       Impact factor: 4.634

8.  Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa.

Authors:  Keren Middelkoop; Landon Myer; Daniella Mark; Sibonisile P Mthimunye; Joalida Smit; Robin Wood; Linda-Gail Bekker
Journal:  J Adolesc Health       Date:  2008-03-06       Impact factor: 5.012

9.  The epidemiology of HIV infection among young people aged 15-24 years in southern Africa.

Authors:  Eleanor Gouws; Karen A Stanecki; Rob Lyerla; Peter D Ghys
Journal:  AIDS       Date:  2008-12       Impact factor: 4.177

10.  Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa.

Authors:  Catherine Slack; Ann Strode; Theodore Fleischer; Glenda Gray; Chitra Ranchod
Journal:  BMC Med Ethics       Date:  2007-05-13       Impact factor: 2.652

View more
  2 in total

1.  Correlates of prevalent HIV infection among adults and adolescents in the Kisumu incidence cohort study, Kisumu, Kenya.

Authors:  Anne Gumbe; Eleanor McLellan-Lemal; Deborah A Gust; Sherri L Pals; Kristen Mahle Gray; Richard Ndivo; Robert T Chen; Lisa A Mills; Timothy K Thomas
Journal:  Int J STD AIDS       Date:  2014-12-12       Impact factor: 1.359

2.  Parental waivers to enable adolescent participation in certain forms of health research: lessons from a South African case study.

Authors:  Ann Strode; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2022-09-24       Impact factor: 2.834

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.